Preferred Label : Satralizumab;

UNII : YB18NF020M;

CAS number : 1535963-91-7;

NCI Metathesaurus CUI : CL553639;

Details


Main resources

You can consult :


https://www.inesss.qc.ca/fileadmin/doc/INESSS/Inscription_medicaments/Avis_au_ministre/Mai_2021/Enspryng_2021_04.pdf
2021
false
false
false
Canada
French
Satralizumab
drug information
Product containing only satralizumab in parenteral dose form (medicinal product form)
Neuromyelitis optica spectrum disorder
satralizumab
injections, subcutaneous
antibodies, monoclonal, humanized

---
Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.